Population
Patients with Duchenne muscular dystrophy (DMD)
Design
Review
Authors
Loading...
Supports further research on antifibrotics in Duchenne muscular dystrophy; leaves open clinical translation pending prospective trials.
Antifibrotic therapies may represent a viable therapeutic approach for Duchenne muscular dystrophy by reducing scar formation and enhancing muscle regeneration.
Zhou et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: